Wassim Abida, Yu Chen, Deaglan Joseph McHugh, Michael J. Morris, Frank Wu, Peng Peng, Katie Hennessy, Hui Wang, Jean Fan, Samir Zaidi. "A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps290